Main Article Content
Abstract
RÉSUMÉ
Objectif. Etudier les VH suivies dans le service de Cardiologie du Centre hospitalier universitaire Gabriel Touré (CHU-GT). Méthodes. L’étude rétrospective a porté sur les dossiers de patients des deux sexes âgés de 16 ans au moins suivis ou hospitalisés dans le service de Cardiologie du CHU-GT de 2010 à 2020. Ont été inclus tous les patients avec une valvulopathie confirmée par échocardiographie. Les données ont été enregistrées dans une base de données Microsoft Access 2013 et analysées par le logiciel IBM SPSS version 20. Résultats. La prévalence des VH était de 1,26%. Le type lésionnel était la fuite valvulaire dans 62,1% des cas, l’atteinte monovalvulaire dans 59,9% des cas avec une participation mitrale de 90%,4. Parmi les atteintes monovalvulaires l’insuffisance mitrale (IM) était la plus fréquente (28,3%) suivie du rétrécissement mitral (RM) ( 24,2%) tandis que l’atteinte bivalvulaire a concerné l’IM et l’insuffisance aortique (IA) dans 15,3 % des cas. La prise en charge était essentiellement médicale (95,5%) et les complications les plus fréquemment retrouvées étaient les troubles du rythme et l’insuffisance cardiaque dans des proportions respectives de 60,5 et 23,6 %. Conclusion. La VH demeurre un problème dont la résolution nécessite des actions d’amélioration du niveau de vie et de prise en charge. Sa surveillance est une nécessité passant en autres par l’amélioration du plateau technique et de l’accessibilité aux soins
ABSTRACT
Objective. To study the RVD followed in the Cardiology department of the University Hospital Gabriel Touré (UH-GT). Methods. The retrospective study focused on patients of both sexes aged at least 16 years followed or hospitalized in the Cardiology department of the CHU-GT from 2010 to 2020. All patients with RVD confirmed by echocardiography were included. The data was recorded in a Microsoft Access 2013 database and analyzed by IBM SPSS version 20 software. Results. The prevalence of RVD was 1.26%. The lesion type was regurgitation in 62.1% of cases, single valve involvement in 59.9% of cases and mitral involvement of 90%,4. Among monovalvular diseases, mitral regurgitation (MR) was the most common (28.3%) followed by mitral stenosis (MS) (24.2%) while bivalvular involvement concerned Mitral and aortic insufficiency in 15.3% of cases. Management was essentially medical (95.5%) and the most frequently found complications were arrhythmias and heart failure in proportions of 60.5 and 23.6% respectively. Conclusion. RVD remains a problem whose resolution requires actions to improve the standard of living and support. Its monitoring is a necessity through, among other things, the improvement of the technical platform and accessibility to care.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Lucas G, Tribouilloy C. [Epidemiology and etiology of acquired heart valve diseases in adults]. Rev Prat. 1. Oktober 2000;50(15):1642–5.
- Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, u. a. Contemporary Presentation and Management of Valvular Heart Disease. Circulation. 1. Oktober 2019;140(14):1156–69.
- Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, u. a. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017. Circulation. 26. Mai 2020;141(21):1670–80.
- Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, u. a. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 28. August 2021;ehab395.
- Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, u. a. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N Engl J Med. 24. August 2017;377(8):713–22.
- Rheumatic Heart Disease [Internet]. [Consulté le 14. Dezember 2021]. Disponible sous: https://www.who.int/news-room/fact-sheets/detail/rheumatic-heart-disease
- Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou J-B, Anisubia B, u. a. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 1. Mai 2016;109(5):321–9.
- DIALLO (B.A.), DIALLO (B.A.), TOURE (M.K.). Morbidité et mortalité cardiovasculaires à Bamako (Mali). Morb Mortal Cardiovasc À Bamako Mali. 1994;
- Coulibaly S. Valvulopathies acquises à Bamako : A propos de 108 cas. Res Fr [Internet]. 23. Februar 2018 [Consulté le 30. Dezember 2021]; Disponible sous: http://www.research-journal.net/fr/Valvulopathies-in-Bamako-108-cases.html
- Oumar BH, Kéita MA, Thiam DC, Souleimane MS, Noumou S, Ibrahima S, u. a. Prevalence, Pattern and Evolution of Rheumatic Heart Disease: About 120 Cases at Mother-Children University Hospital Luxembourg (MC UHL), Bamako (Mali). World J Cardiovasc Dis. 12. Juli 2018;8(7):319–27.
- Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. Geneva: World Health Organization; 2004. 122 p. (Technical report series / World Health Organization).
- Reményi, Bo, Nigel Wilson, Andrew Steer, Beatriz Ferreira, Joseph Kado, Krishna Kumar, John Lawrenson, et al. “World Heart Federation Criteria for Echocardiographic Diagnosis of Rheumatic Heart Disease—an Evidence-Based Guideline.” Nature Reviews Cardiology 9, no. 5 (May 2012): 297–309. https://doi.org/10.1038/nrcardio.2012.7.
- Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study. Eur Heart J. 2. März 2010;31(6):719–27.
- Monsuez J-J. Valvulopathies rhumatismales. Arch Mal Coeur Vaiss - Prat. 1. September 2011;2011(200):28–31.
- Marijon E, Ferreira B, Paquet C, Jouven X. Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. N Engl J Med. 2007;7.
- Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease [Internet]. [Consulté le 23. November 2021]. Disponible sous: https://login.research4life.org/tacsgr1onlinelibrary_wiley_com/doi/epdf/10.1111/tmi.13235
- Kramoh KE, N’Goran YNK, Aké-Traboulsi E, Konin KC, Boka BC, Koffi DBJ, u. a. Cardites rhumatismales en Côte d’Ivoire : évolution de la prévalence hospitalière durant la décennie 2000–2009. Ann Cardiol Angéiologie. 1. Februar 2013;62(1):34–7.
- Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, u. a. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 7. Mai 2015;36(18):1115–22.
- Longenecker CT, Morris SR, Aliku TO, Beaton A, Costa MA, Kamya MR, u. a. Rheumatic Heart Disease Treatment Cascade in Uganda. Circ Cardiovasc Qual Outcomes [Internet]. November 2017 [Consulté le 3. Januar 2022];10(11). Disponible sous: https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.117.004037
- Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, u. a. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué. Cardiovasc J Afr. 6. Juli 2016;27(3):184–1847. .
References
Lucas G, Tribouilloy C. [Epidemiology and etiology of acquired heart valve diseases in adults]. Rev Prat. 1. Oktober 2000;50(15):1642–5.
Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, u. a. Contemporary Presentation and Management of Valvular Heart Disease. Circulation. 1. Oktober 2019;140(14):1156–69.
Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, u. a. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017. Circulation. 26. Mai 2020;141(21):1670–80.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, u. a. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 28. August 2021;ehab395.
Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, u. a. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. N Engl J Med. 24. August 2017;377(8):713–22.
Rheumatic Heart Disease [Internet]. [Consulté le 14. Dezember 2021]. Disponible sous: https://www.who.int/news-room/fact-sheets/detail/rheumatic-heart-disease
Kingué S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou J-B, Anisubia B, u. a. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis. 1. Mai 2016;109(5):321–9.
DIALLO (B.A.), DIALLO (B.A.), TOURE (M.K.). Morbidité et mortalité cardiovasculaires à Bamako (Mali). Morb Mortal Cardiovasc À Bamako Mali. 1994;
Coulibaly S. Valvulopathies acquises à Bamako : A propos de 108 cas. Res Fr [Internet]. 23. Februar 2018 [Consulté le 30. Dezember 2021]; Disponible sous: http://www.research-journal.net/fr/Valvulopathies-in-Bamako-108-cases.html
Oumar BH, Kéita MA, Thiam DC, Souleimane MS, Noumou S, Ibrahima S, u. a. Prevalence, Pattern and Evolution of Rheumatic Heart Disease: About 120 Cases at Mother-Children University Hospital Luxembourg (MC UHL), Bamako (Mali). World J Cardiovasc Dis. 12. Juli 2018;8(7):319–27.
Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. Geneva: World Health Organization; 2004. 122 p. (Technical report series / World Health Organization).
Reményi, Bo, Nigel Wilson, Andrew Steer, Beatriz Ferreira, Joseph Kado, Krishna Kumar, John Lawrenson, et al. “World Heart Federation Criteria for Echocardiographic Diagnosis of Rheumatic Heart Disease—an Evidence-Based Guideline.” Nature Reviews Cardiology 9, no. 5 (May 2012): 297–309. https://doi.org/10.1038/nrcardio.2012.7.
Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study. Eur Heart J. 2. März 2010;31(6):719–27.
Monsuez J-J. Valvulopathies rhumatismales. Arch Mal Coeur Vaiss - Prat. 1. September 2011;2011(200):28–31.
Marijon E, Ferreira B, Paquet C, Jouven X. Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. N Engl J Med. 2007;7.
Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease [Internet]. [Consulté le 23. November 2021]. Disponible sous: https://login.research4life.org/tacsgr1onlinelibrary_wiley_com/doi/epdf/10.1111/tmi.13235
Kramoh KE, N’Goran YNK, Aké-Traboulsi E, Konin KC, Boka BC, Koffi DBJ, u. a. Cardites rhumatismales en Côte d’Ivoire : évolution de la prévalence hospitalière durant la décennie 2000–2009. Ann Cardiol Angéiologie. 1. Februar 2013;62(1):34–7.
Zühlke L, Engel ME, Karthikeyan G, Rangarajan S, Mackie P, Cupido B, u. a. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur Heart J. 7. Mai 2015;36(18):1115–22.
Longenecker CT, Morris SR, Aliku TO, Beaton A, Costa MA, Kamya MR, u. a. Rheumatic Heart Disease Treatment Cascade in Uganda. Circ Cardiovasc Qual Outcomes [Internet]. November 2017 [Consulté le 3. Januar 2022];10(11). Disponible sous: https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.117.004037
Watkins D, Zuhlke L, Engel M, Daniels R, Francis V, Shaboodien G, u. a. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué. Cardiovasc J Afr. 6. Juli 2016;27(3):184–1847. .